The NHS is offering autumn Covid boosters to the most vulnerable in October. Many pharmacies also now sell the Covid jab ...

AZN's Daiichi Sankyo-partnered datopotamab deruxtecan fails to show overall survival benefits in a breast cancer study. Stock ...

When “the Greater Good” Matters The business pages, and now the mainstream media, have been dominated over the last week with news of Pfizer’s proposed $106bn takeover of AstraZeneca, which would make ...

AstraZeneca is continuing to study AZD8205 as a monotherapy in dose optimization expansion cohorts of patients with ...

Responding to rising mpox cases in Africa, the World Health Organization declared a public health emergency of international ...

Patients with HER2-positive advanced or metastatic breast cancer received trastuzumab deruxtecan every 3 weeks.

Pfizer chief executive Ian Read is to go head-to-head with AstraZeneca's Pascal Soriot in two parliamentary hearings to argue for the future of the UK-based company. The two CEOs have been called ...

Earlier switch to atezolizumab after run-in with vemurafenib plus cobimetinib showed promise in improving OS rates in BRAF ...

This summary covers various health news: a Nipah virus death in Kerala, Gaza's polio vaccination coverage success, brain ...